Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double‐blind meal test early‐phase study-Reference-Cited by-同舟云学术

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double‐blind meal test early‐phase study

Published:2021-10-24 Issue:2 Volume:24 Page:196-203
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Kazda Christof¹^ORCID,Leohr Jennifer¹^ORCID,Liu Rong¹,Reddy Shobha¹,Dellva Mary Anne¹,Loh Mei Teng¹,Hardy Thomas¹,Plum‐Mörschel Leona²

Affiliation:

1. Eli Lilly and Company Indianapolis Indiana USA

2. Profil Mainz Germany

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14563

Reference15 articles.

1. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018

2. Insulin Strategies for Primary Care Providers

3. Ultrafast-Acting Insulins: State of the Art

4. Prandial Glycaemia After a Carbohydrate-rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin

5. Humalog® [package insert]. Indianapolis IN: Eli Lilly and Company; 2017.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The first biosimilar of ultra-rapid insulin lispro: results of a double-blind randomised clamp study;Meditsinskiy sovet = Medical Council;2024-09-03

2. Review of data on comparative pharmacokinetics, pharmacodynamics, efficacy and safety of the superfast insulin drug lispro;FOCUS. Endocrinology;2024-05-13

3. Evolution of biosynthetic human insulin and its analogues for diabetes management;Advances in Protein Chemistry and Structural Biology;2024

4. Faster and faster: meeting the challenges of delayed insulin action during pregnancy;The Lancet Diabetes & Endocrinology;2023-11

5. Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion;Diabetes, Obesity and Metabolism;2023-10-09